HB3834
β Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date.
PASSES β House (68β23)
by Rep. Stan May
Boring Official Vote
YEA (66)
NAY (23)
ABSENT (8)
Democrats β 94.0% π’ (17:0)
Republicans β 62.0% π’ (49:23)
ο»Ώ